Clinical Trials Browser

Phase 1/2 × Has announcements × Burkitt Lymphoma × Clear all

NCT04404660 2025-09-09

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Phase 1/2 Active not recruiting

153 enrolled 1 FDA

Burkitt Lymphoma, Recurrence